focus -WSS

focus

author：Wikipedia 2025-09-29 10:34:40 - browse：14919

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： The United States must get value

focus

WSS

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

The White House hikes tariffs on plastic syringes made in China

WuXi Biologics beefs up its lobbying operation

The Karikó problem: Lessons for funding basic research

Congress extends some pandemic preparedness programs

Cherokee Nation medical school graduates its first class

entertainment

focus

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

CVS is willing to dump 10% of its Medicare Advantage members

Tori Bowie and the unacceptable rates of Black maternal death

Galapagos to make CAR

Activists slam private health insurers over coverage restrictions

Stop Congress from blocking public access to science

Alkermes shareholders re

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

focus

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Will an HIV vaccine ever be a reality?

Congress extends some pandemic preparedness programs

The stability of $0 premiums in Medicare Advantage

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

CDC picks Alphabet's Verily for wasterwater surveillance contract

focus

focus

focus

hotspot